These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 7613557)

  • 41. Impact of intravesical chemotherapy on recurrence rate of recurrent superficial transitional cell carcinoma of the bladder: results of a meta-analysis.
    Huncharek M; McGarry R; Kupelnick B
    Anticancer Res; 2001; 21(1B):765-9. PubMed ID: 11299841
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparing methods for calculating confidence intervals for vaccine efficacy.
    Ewell M
    Stat Med; 1996 Nov 15-30; 15(21-22):2379-92. PubMed ID: 8931208
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Influence diagnostics for two-component Poisson mixture regression models: applications in public health.
    Xiang L; Yau KK; Lee AH; Fung WK
    Stat Med; 2005 Oct; 24(19):3053-71. PubMed ID: 16149127
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Analysis of a within-subject design with covariates.
    Patel HI
    J Biopharm Stat; 1997 Jul; 7(3):369-81. PubMed ID: 9252831
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Bayesian methods of analysis for cluster randomized trials with count outcome data.
    Clark AB; Bachmann MO
    Stat Med; 2010 Jan; 29(2):199-209. PubMed ID: 19856321
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Development of planning level transportation safety tools using Geographically Weighted Poisson Regression.
    Hadayeghi A; Shalaby AS; Persaud BN
    Accid Anal Prev; 2010 Mar; 42(2):676-88. PubMed ID: 20159094
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Methodological aspects of biostatistics and epidemiology in a clinical trial].
    Suárez E; Pérez CM
    P R Health Sci J; 1999 Mar; 18(1):23-30. PubMed ID: 10343983
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Bayesian perspectives for epidemiological research. II. Regression analysis.
    Greenland S
    Int J Epidemiol; 2007 Feb; 36(1):195-202. PubMed ID: 17329317
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Analyzing bivariate repeated measures for discrete and continuous outcome variables.
    Rochon J
    Biometrics; 1996 Jun; 52(2):740-50. PubMed ID: 8672710
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Statistical methods for the analysis of relapse data in MS clinical trials.
    Wang YC; Meyerson L; Tang YQ; Qian N
    J Neurol Sci; 2009 Oct; 285(1-2):206-11. PubMed ID: 19709676
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Bayesian estimation of cost-effectiveness from censored data.
    Heitjan DF; Kim CY; Li H
    Stat Med; 2004 Apr; 23(8):1297-309. PubMed ID: 15083484
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The randomized clinical trial: a prerequisite for rational therapy.
    Staquet M
    Eur Urol; 1976; 2(6):265-70. PubMed ID: 829222
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Neoadjuvant chemotherapy in invasive bladder cancer. Trial design.
    Parmer MK
    Prog Clin Biol Res; 1990; 353():115-8. PubMed ID: 2217408
    [No Abstract]   [Full Text] [Related]  

  • 54. Application of generalized estimating equations to a dental randomized clinical trial.
    Hadgu A; Koch G
    J Biopharm Stat; 1999 Mar; 9(1):161-78. PubMed ID: 10091916
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Analysis of overdispersed count data by mixtures of Poisson variables and Poisson processes.
    Hougaard P; Lee ML; Whitmore GA
    Biometrics; 1997 Dec; 53(4):1225-38. PubMed ID: 9423246
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Issues in use of SAS PROC.MIXED to test the significance of treatment effects in controlled clinical trials.
    Ahn C; Tonidandel S; Overall JE
    J Biopharm Stat; 2000 May; 10(2):265-86. PubMed ID: 10803729
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Analysis of exacerbation rates in asthma and chronic obstructive pulmonary disease: example from the TRISTAN study.
    Keene ON; Jones MR; Lane PW; Anderson J
    Pharm Stat; 2007; 6(2):89-97. PubMed ID: 17230434
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Zero-inflated generalized Poisson regression mixture model for mapping quantitative trait loci underlying count trait with many zeros.
    Cui Y; Yang W
    J Theor Biol; 2009 Jan; 256(2):276-85. PubMed ID: 18977361
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A two-state Markov mixture model for a time series of epileptic seizure counts.
    Albert PS
    Biometrics; 1991 Dec; 47(4):1371-81. PubMed ID: 1786324
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Administrative and artificial censoring in censored regression models.
    Joffe MM
    Stat Med; 2001 Aug; 20(15):2287-304. PubMed ID: 11468764
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.